Zinbryta (Daclizumab) by Biogen/AbbVie
January 2018
Zinbryta (Daclizumab) by Biogen/AbbVie Zinbryta (Daclizumab) by Biogen/AbbVie Zinbryta (Daclizumab) by Biogen/AbbVie The manufacturer is removing the drug from the worldwide market due to safety concerns, including reports of severe liver damage and immune-related conditions....
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote